Supplementary Table 1.
2019 n (%) |
2020 n (%) |
|
---|---|---|
Age 18 to 44 years | ||
Screening | 1279 (11.5) | 1036 (10.7) |
Surveillance | 338 (3.0) | 275 (2.8) |
FIT positive | 17 (0.2) | 10 (0.1) |
Diagnostic | 9208 (82.9) | 8115 (83.9) |
Unknown | 264 (2.4) | 241 (2.5) |
Total | 11,106 (100) | 9,677 (100) |
Age 45 to 75 years | ||
Screening | 16,102 (18.0) | 9108 (14.3) |
Surveillance | 15,589 (17.4) | 9519 (14.9) |
FIT positive | 14,532 (16.2) | 11,623 (18.2) |
Diagnostic | 41,105 (45.9) | 32,144 (50.5) |
Unknown | 2207 (2.5) | 1315 (2.1) |
Total | 89,535 (100) | 63,709 (100) |
Age 76 to 89 years | ||
Screening | 724 (7.3) | 449 (6.0) |
Surveillance | 2164 (21.7) | 1362 (18.2) |
FIT positive | 137 (1.4) | 115 (1.5) |
Diagnostic | 6878 (69.1) | 5524 (73.9) |
Unknown | 50 (0.5) | 27 (0.4) |
Total | 9953 (100) | 7477 (100) |